Inventor
WALZ JULIANE
DE15 patents
Patents
15 patentsUS10450346B2Oct 22, 2019
Immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemia (CLL)
IMMATICS BIOTECHNOLOGIES GMBH1 citations73
US10364271B2Jul 30, 2019
Immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemia (CLL)
IMMATICS BIOTECHNOLOGIES GMBH2 citations73
US10906938B2Feb 2, 2021
Cell epitopes and combination of cell epitopes for use in the immunotherapy of myeloma and other cancers
IMMATICS BIOTECHNOLOGIES GMBH1 citations72
US10925949B2Feb 23, 2021
Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (AML)
IMMATICS BIOTECHNOLOGIES GMBH0 citations62
US10919933B2Feb 16, 2021
Cell epitopes and combination of cell epitopes for use in the immunotherapy of myeloma and other cancers
IMMATICS BIOTECHNOLOGIES GMBH0 citations62
US10899794B2Jan 26, 2021
Cell epitopes and combination of cell epitopes for use in the immunotherapy of myeloma and other cancers
IMMATICS BIOTECHNOLOGIES GMBH0 citations62
US10898562B1Jan 26, 2021
Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (AML)
IMMATICS BIOTECHNOLOGIES GMBH0 citations62
US10875892B2Dec 29, 2020
Immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemia (CLL)
IMMATICS BIOTECHNOLOGIES GMBH0 citations52
US10730910B2Aug 4, 2020
Immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemia (CLL)
IMMATICS BIOTECHNOLOGIES GMBH0 citations52
US10570175B2Feb 25, 2020
Immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemia (CLL)
IMMATICS BIOTECHNOLOGIES GMBH0 citations52
US10813985B2Oct 27, 2020
Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (aml)
IMMATICS BIOTECHNOLOGIES GMBH0 citations51
US10799571B2Oct 13, 2020
Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (AML)
IMMATICS BIOTECHNOLOGIES GMBH0 citations51
US10781233B2Sep 22, 2020
Cell epitopes and combination of cell epitopes for use in the immunotherapy of myeloma and other cancers
IMMATICS BIOTECHNOLOGIES GMBH0 citations51
US10668137B2Jun 2, 2020
Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (AML)
IMMATICS BIOTECHNOLOGIES GMBH0 citations51
US10525115B2Jan 7, 2020
Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (AML)
IMMATICS BIOTECHNOLOGIES GMBH0 citations51